11th Clinical Research Conference

"The future cannot wait for Greece"

Rapid developments are foreseen in the near future in the clinical research sector on an international level. The New European Regulation, the increasing use of digital technology, and Decentralized Clinical Trials seem to be the drivers behind these developments.

Greece is still lagging behind in this respect, despite the government’s recent steps in the right direction. For example, a ministerial decision lifted a major counter incentive for hospital administrations and now the revenues from clinical research are calculated separately from state subsidies. However, that is not enough. Coordinated efforts are required to cut through the red tape once and for all at a hospital level, and executive training is needed to change the culture on clinical research at the National Health System (ESY). In a move in this direction, the decision has been made for special offices with suitably trained personnel to be created at 15 major hospitals.

All the latest developments on clinical research will be discussed at the 11th Clinical Research Conference, the hybrid event to be held on December 13 at Divani Caravel Hotel. The conference is being organized by ethosEVENTS in partnership with the health information portal virus.com.gr and health policy magazine Pharma & Health Business.

Coordinator of the conference will be Mr. Emilios Negis, journalist and editor of Pharma & Health Business and Virus.com.gr.

Closed (Hybrid) Lobbing Workshop

During the works of the 11th Clinical Research Conference a Closed Lobbing Workshop will be held with the participation of the General Secretary οf Health Services, Mr Ioannis Kotsiopoulos, hospital directors and executives, and Health Regions from all over Greece.

General Secretary Of Health Services (PhD, MSc, PGDip, BSc)

The workshop is organized as a hybrid event, with physical presence of participants and top executives of the conference sponsors, while the option of digital attendance will be available through LiveOn Expo Complex.

Coordinator of the closed meeting will be Mr. Emilios Negis, journalist and editor of Pharma & Health Business and Virus.com.gr.

The 11th Clinical Research Conference includes important speeches and panels with the following key matters.

Panel 1: Measures and policies for the promotion of clinical research in Greece.

Despite the pandemic, there has been an increase of approved clinical research in Greece over the past 3 years. Nevertheless, Greece still ranks near the bottom in the EU, mainly due to bureaucracy at a hospital and Health Region level.Currently, clinical research with a total budget of approximately €80 million is approved in Greece annually. Unfortunately, however, we have no reliable data regarding the research that is ultimately carried out and the amounts absorbed on an annual basis.On an EU level approximately €35-€40 billion are invested annually in clinical research. If we take into account the level of the scientific personnel, which remains of a high standard despite the problems being faced, the size of country, and the health system, then it is estimated that Greece could attract 4 or even 5 times more resources for clinical research.Specialists note that we need to simplify processes and utilize new technologies. We need a change of culture at hospitals, and director and employee training on the value of clinical research is required.

Recently there was an important provision in the right direction. The new provision states that the amounts recorded as income at hospitals from clinical research will be in excess of the appropriations that have been provided for in the state budget.

The necessity to remove this counter incentive had been highlighted at the committee that had been formed regarding this matter last year under secretary general Mr. Giannis Kotsiopoulos. At the same time, the Ministry of Health is promoting the creation of special clinical research offices at 15 major hospitals, although there have been delays in the implementation of this measure.

The pandemic brought about changes in the implementation of clinical research thanks to the use of new technologies, which are here to stay. Experts note that it is a golden opportunity for Greece to invest in the utilization of technologies such as Artificial Intelligence and Big Data. At the same time, they underline that Greece needs to focus on specific therapeutic fields, such as hematology and oncology.

Subjects

  • What are the obstacles in carrying out clinical research in Greece and what interventions are necessary?
  • Clinical research register: Current status, challenge
  • Does the current institutional framework suffice? Are new institutional measures required and in what direction?
  • How can bureaucracy be dealt with on a hospital and Health Region level?
  • How can hospitals be reorganized to attract clinical research?

Panel 2: New European Regulation: Prospects-opportunities-impacts.

On January 31, 2022, the new EU regulation on clinical trials was implemented, harmonizing the procedures for submission, evaluation, and supervision in all member-states.In that same framework the operation of the new Clinical Trials Information System (CTIS) will be launched. It will be the exclusive means by which sponsors and regulatory authorities will apply for and evaluate clinical data, while it will include a database search engine for health-care professionals, patients, and the broader public.As announced by EMA, a transitional period of 3 years is provided for, which means that by January 2025 all trials approved based on the current regulation will then be regulated by the new regulation, and must to have been moved to the CTIS.With the launch of the CTIS, sponsors will have the option of submitting clinical trial applications to as many as 30 countries in the EU and the EEC at the same time, using the same documentation. According to the EU, this will enhance Europe’s position in clinical research. At the same time, the public will obtain access to detailed information and the conclusions of all the clinical trials that are on the system.This new regulation is part of the Accelerating Clinical Trials in the EU (ACT EU) program for the 2022-2026 period. The goal is to further develop the EU as a clinical research hub, to promote the development of high quality, safe, and effective medicines, and to better incorporate clinical research in the European health system.

Naturally, three serious questions arise:

  • What stage are we at internationally?
  • Are we ready in Greece?
  • What is the impact on Greece?

Panel 3: The utilization of new digital technologies and decentralized clinical research.

A wealth of research indicates that traditional clinical trials are currently facing serious obstacles in registering patients, in long travel, or due to the time spent at hospitals or single-trial centers. For example, research has shown that 70% of participants live at least 2 hours away from the research center.One of the dominant new trends internationally in the clinical trials sector is the utilization of new technologies in carrying out decentralized research. This research utilizes digital technologies so that the entire research or part of it can be carried out from the patient’s home or from the office of a local doctor, instead of the main research center, such as a major hospital.The main advantage of decentralized clinical research that has been identified by researchers is ease of participation, as it allows for flexibility, it requires fewer personal visits to the hospital, it allows for passive data collection, and it removes obstacles to participation, such as location factors, available time, and travel.Furthermore, there are several aspects of added value to decentralized clinical trials, with regard to the research taking place.

  • Firstly, there is a better generalization of trial results, as decentralized research allows for different and representative cohorts of patients, thus improving the quality of the research.
  • Secondly, there is better patient commitment, as it allows participants to self-manage.

Other benefits include improvements in participant recruitment and retention, greater commitment and variety, and trial implementation cost reduction.

On the other hand, however, there is a significant disadvantage: Patient safety. There is a risk of physical harm to participants if they administer the drug under trial improperly or unsafely. Furthermore, the complexity of these remote clinical trials may lead to the patients misunderstanding the purpose of the trial, resulting in reduced compliance. This may ultimately lead to inaccurate research findings.

Subjects – questions:

  • Why is decentralized clinical research gaining ground internationally?
  • What are its advantages and disadvantages?
  • What opportunities are arising for Greece?
  • How can we efficiently utilize new technologies in the implementation of clinical trials?

Audience:

  • Political Leadership of the Ministry of Health
  • Representatives of the National Medicine Organization
  • Executives of pharmaceutical companies
  • Representatives of health agencies
  • Distinguished doctors
  • Representatives of Patient Associations
  • Executives of clinical trial companies
  • Journalists
Local Country Site Activation Manager for Greece, IQVIA
Quality Assurance Project Manager – Biotechnology Operations, DEMO
Clinical Research Fellow, Faculty of Medicine, University of Thessaly, Larisa, Greece
MD, Msc in Public Health, General Practitioner/Family Physician, General Secretary of the Athens Medical Society, Greek NHS Consultant, Vari Health Centre, Athens
Acting Head, Clinical Trials Dept. Pharmaceutical Studies & Research Dir, EOF
President HACRO (Hellenic Association of CROs), President & CEO Coronis Research SA
Medical Director Greece & Cyprus, Southern Mediterranean & Black Sea (SMBS) Cluster Medical Director, Bayer
Managing Director, IQVIA Hellas
Clinical Studies Unit Head Sanofi
Clinical Operations Manager, Medical Department, PHARMASERVE-LILLY
Medical Director, PHARMASERVE – LILLY, Coordinator at SFEE Working Group for Clinical Trials
Programme Manager, Journalist

Silver Sponsors

IQVIA

Sponsors

BAYER

Premium Corporate Participations

Corporate Participations

Under the Auspices of

harco_site
PIF_site
sfee-40-en-logo
pef-new-2022
elefi_site

Communication Sponsors

VIRUS_NEW
phb_logo
BANKS
star_ken_el_logo
tvstar_new_1
thesnew_site
kriti24_site.png
piraeus365gr_logo
xanthinews_site
xrima
xrimaweek
insuranceworld
insuranceworldgr

GOLD SPONSOR (15,000€ + VAT)

  • Sponsors will be prominently featured throughout the conference’s promotional material (e-newsletters, e-mail updates, landing pages, reports, etc.).
  • The option is provided for the publication of an interview of a high-ranking executive in Pharma & Health Business magazine, to be reposted on the virus.com.gr portal.
  • One sponsor executive is entitled to a ten-minute (10) speech.
  • Sponsors are entitled to have an executive participate in a conference panel.
  • Sponsors are entitled to have three (3) executives physically present and three (3) executives participate digitally at the Closed (Hybrid) Lobbing Workshop.
  • The sponsor’s logo (and/or a design containing it) will be prominently featured on the graphics of the conference’s main website and on the graphics of the LiveOn Expo Complex (signs on the building’s exterior, in the Lobby/Zone Α, in the VIP Lounge in the Conference Center Lobby, and in the Conference Center (Auditorium) halls where the event will be broadcast live).
  • Sponsors are entitled to a Premium 3D Digital Stand at the LiveOn Expo Complex Sponsors Hall. The stand will include the following material (up to 30 MB): 1. Company Logo (area where the Sponsor’s corporate sign and brand name will be presented in a photographic composition), 2. Digital Secretariat (area where visitors will be able to leave their contact details, get information on the company profile (500 words maximum), download the company profile and request a meeting with a Sponsor’s representative), 3. Company Video (area where visitors will have access to a company presentation video – of 5′ maximum duration), 4. Product Promotion Placements (2x) (two placements of photographic material where visitors will be able to get information on the company’s products), 5. Meeting Point (where visitors will have the opportunity to meet with company’s representatives who are present at the stand (their profiles will be visible on pop-ups) and interact with them (through pop-ups) by instant chat, instant or scheduled video call, instant or scheduled B2B meeting) and 6. Product Catalogue Placements (2x).
  • At the Digital Stand, up to eight (8) executives of the Sponsor will be able to connect and communicate online. Visitors who request some form of communication with an executive, will automatically be notified of the latter’s contact information (e-business card).
  • They are entitled to space to set up a kiosk, maximum dimensions 3m x 3m, in the lobby of the hotel where the conference will be held.
  • They are entitled to fifty (50) invitations to attend the conference via the LiveOn electronic platform.
  • They are entitled to three (3) eight-person round tables (24 people) in the conference area.
  • Sponsors may opt to screen an advertisement spot (20” maximum duration). This ad spot may be played up to three (3) times during the conference’s advertisement slots.
  • Sponsors will be promoted via the organizer’s social media (Facebook and LinkedIn) with three (3) “featured” posts.
  • They are entitled to include up to (30 MB) of promotional material in the conference’s MyEventXPack (digital tote bag).
  • They shall receive an extensive report of the conference.

SILVER SPONSOR (10,000€ + VAT)

  • Sponsors will be prominently featured throughout the conference’s promotional material (e-newsletters, e-mail updates, landing pages, reports, etc.).
  • The option is provided for the publication of an interview of a high-ranking executive on the com.gr portal.
  • One sponsor executive is entitled to a ten-minute (10) speech or to participate in a conference panel.
  • Sponsors are entitled to have two (2) executives physically present and two (2) executives participate digitally at the Closed (Hybrid) Lobbing Workshop.
  • The sponsor’s logo (and/or a design containing it) will be prominently featured on the graphics of the conference’s main website and on the graphics of the LiveOn Expo Complex (signs on the building’s exterior, in the Lobby/Zone Α, in the VIP Lounge in the Conference Center Lobby, and in the Conference Center (Auditorium) halls where the event will be broadcast live).
  • Sponsors are entitled to a Premium 3D Digital Standat the LiveOn Expo Complex Sponsors Hall. The stand will include the following material (up to 20 MB): 1. Company Logo (area where the Sponsor’s corporate sign and brand name will be presented in a photographic composition), 2. Digital Secretariat (area where visitors will be able to leave their contact details, get information on the company profile (500 words maximum), download the company profile and request a meeting with a Sponsor’s representative), 3. Company Video (area where visitors will have access to a company presentation video – of 5′ maximum duration), 4. Product Promotion Placements (2x) (two placements of photographic material where visitors will be able to get information on the company’s products). 5. Meeting Point (where visitors will have the opportunity to meet with company’s representatives who are present at the stand (their profiles will be visible on pop-ups) and interact with them (through pop-ups) by instant chat, instant or scheduled video call, instant or scheduled B2B meeting) and 6. Product Catalogue Placements (2x).
  • At the Digital Stand, up to six (6) executives of the Sponsor will be able to connect and communicate online . Visitors who request some form of communication with an executive, will automatically be notified of the latter’s contact information (e-business card).
  • They are entitled to space to set up a kiosk, maximum dimensions 3m x 2m, in the lobby of the hotel where the conference will be held.
  • They are entitled to forty (40) invitations to attend the conference via the LiveOn electronic platform.
  • They are entitled to two (2) eight-person round tables (16 people) in the conference area.
  • Sponsors may opt to screen an advertisement spot (20” maximum duration). This ad spot may be played up to two (2) times during the conference’s advertisement slots.
  • Sponsors will be promoted via the organizer’s social media (Facebook and LinkedIn) with two (2) “featured” posts.
  • They are entitled to include up to (20 MB) of promotional material in the conference’s MyEventXPack (digital tote bag).
  • They shall receive an extensive report of the conference.

SPONSOR (5,000€ + VAT)

  • Sponsors will be prominently featured throughout the conference’s promotional material (e-newsletters, e-mail updates, landing pages, reports, etc.).
  • Sponsors are entitled to have one (1) executive physically present and one (1) executive participate digitally at the Closed (Hybrid) Lobbing Workshop.
  • The sponsor’s logo (and/or a design containing it) will be prominently featured on the graphics of the conference’s main website and on the graphics of the LiveOn Expo Complex (signs in the Lobby/Zone Α, in the Conference Center Lobby — subject to availability — and in the Conference Center (Auditorium) halls where the event will be broadcast live).
  • Sponsors are entitled to an Advanced 3D Digital Stand at the LiveOn Expo Complex Sponsors Hall. The stand will include the following material (up to 10 MB): 1. Company Logo (area where the Sponsor’s corporate sign and brand name will be presented in a photographic composition), 2. Digital Secretariat (area where visitors will be able to leave their contact details, get information on the company profile (500 words maximum), download the company profile and request a meeting with a Sponsor’s representative), 3. Company Video (area where visitors will have access to a company presentation video – of 5′ maximum duration), 4. Product Promotion Placement (1x) (one placement of photographic material where visitors could get information on the company’s products), 5. Meeting Point (where visitors will have the opportunity to meet with company’s representatives who are present at the stand (their profiles will be visible on pop-ups) and interact with them (through pop-ups) by instant chat, instant or scheduled video call, instant or scheduled B2B meeting) and 6. Product Catalogue Placement (1x).
  • At the Digital Stand, up to four (4) executives of the Sponsor will be able to connect and communicate online. Visitors who request some form of communication with an executive, will automatically be notified of the latter’s contact information (e-business card).
  • They are entitled to space to set up a kiosk, maximum dimensions 2m x 2m, in the lobby of the hotel where the conference will be held.
  • They are entitled to thirty (30) invitations to attend the conference via the LiveOn electronic platform.
  • They are entitled to one (1) eight-person round table (8 people) in the conference area.
  • Sponsors may opt to screen an advertisement spot (20” maximum duration). This ad spot may be played once (1) during the conference’s advertisement slots.
  • Sponsors will be promoted via the organizer’s social media (Facebook and LinkedIn) with one (1) “featured” post.
  • They are entitled to include up to (10 MB) of promotional material in the conference’s MyEventXPack (digital tote bag).
  • They shall receive an extensive report of the conference.

PREMIUM CORPORATE PARTICIPATION (3,000€ + VAT)

  • Sponsors will be featured throughout the conference’s promotional material (e-newsletters, e-mail updates, landing pages, reports, etc.).
  • Sponsors are entitled to have one (1) executive participate physically or digitally in the Closed (Hybrid) Lobbing Workshop.
  • The sponsor’s logo (and/or a design containing it) will be featured on the graphics of the conference’s main website and on the graphics of the LiveOn Expo Complex (signs in the Lobby/Zone B — subject to availability —, in the Conference Center lobby — subject to availability —, and in the Conference Center (Auditorium) halls where the event will be broadcast live).
  • Sponsors are entitled to a Standard 3D Digital Stand at the LiveOn Expo Complex Sponsors Hall. The stand will include the following material (up to 8MB): 1. Company Logo (area where the Sponsor’s corporate sign and brand name will be presented in a photographic composition), 2. Digital Secretariat (area where visitors could leave their contact details, get information on the company profile (150 words maximum), 3. Company Video (area where visitors will have access to a company presentation video – of 3′ maximum duration), 4. Product Promotion Placement (1x) (one placement of photographic material where visitors could get information on the company’s products).
  • They are entitled to display one (1) roll up banner, maximum dimensions 0.85m x 2.00m, in the lobby of the hotel where the conference will be held.
  • They are entitled to twenty (20) invitations to attend the conference via the LiveOn electronic platform.
  • They are entitled to invite four (4) guests to attend the conference in person.
  • They are entitled to include up to (8 MB) of promotional material in the conference’s MyEventXPack (digital tote bag).
  • They shall receive an extensive report of the conference.

CORPORATE PARTICIPATION (1,500€ + VAT)

  • The sponsor’s logo will be featured on the conference’s graphics (on the conference main website, the Sponsor section landing page, and the presentation – speech pages).
  • Sponsors are entitled to have one (1) executive participate digitally in the Closed (Hybrid) Lobbing Workshop.
  • They are entitled to ten (10) invitations to attend the conference via the LiveOn electronic platform.
  • They are entitled to invite two (2) guests to attend the conference in person.
  • They are entitled to include up to (5 MB) of promotional material in the conference’s MyEventXPack (digital tote bag).
  • They shall receive an extensive report of the conference.

INDIVIDUAL PARTICIPATION

€250 + 24% VAT – hybrid participation (physically & digitally present via the LiveOn Expo Complex)

€90 + 24% VAT – digital participation (via the LiveOn Expo Complex)

Provisions per individual participations:

  • Participation in conference proceedings.
  • Full utilization of the advanced digital capabilities of the LiveOn Expo Complex (networking, XPack, video calls & chats).
  • Conference attendance certificate (to be sent by e-mail)
  • Online exchange of contact details and personal communication with speakers, conference participants, and participating sponsor executives through the event’s Networking Hub.
  • All participants will receive a detailed report of the conference (including speaker presentations, videos, and photos).
Event Details
    Contact

    For information on sponsorship programs

    Konstantinos Ouzounis, CEO, ethosGROUP
    Tel:+30 210 998 4864,
    e-mail: [email protected]
     
    Christos Charalambakis, Key Account Manager, 
    Τηλ:+30 210 998 4915, 
    e-mail: [email protected]

    Program Manager

    Emilios Negis, Managing Editor, Pharma & Health Business, virus.com.gr,
    Τηλ:+30 210 998 4950

    For information on the program & Auspices

    Mariana Vazaiou, Head of Events Content,
    Τel:+30 210 998 4932,
     
    Markella Farkona, Events Programme Executive,
    Τel:+30 210 998 4865,

    Marketing & Communication Sponsors

    Andreas Baltas, Group Digital Marketing Specialist,
    Tel:+30 210 998 4906,
     
    Georgia Koutsougera, Marketing Assistant,
    Tel:+30 210 998 4934,

    Event Coordinator & Registrations Support

    Konstantinos Salvarlis, Events Director,
    Tel:+30 210 998 4909,
     
    Aris Lavdis, Events Manager,
    Tel:+30 210 998 4814,

    Individual Participations

    Loretta Boura, Key Account Executive,
    Tel:+30 210 998 4902
    Past Events

    Clinical Research Conference 2021
    Conference | Report

    9th Clinical Research Conference
    ConferenceReport

    8th Clinical Research Conference
    Conference | Report